RABISIN, ενέσιμο εναιώρημα

Ima dovoljenje za promet

RABIES VIRUS

Prenes kot PDF

Informacije o zdravilu

Ime zdravila:

RABISIN, ενέσιμο εναιώρημα

Učinkovina:

Na voljo samo v English

Ciljne živalske vrste:

govedo
Na voljo samo v Bulgarian Spanish Czech Danish German Estonian Greek English French Italian Latvian Lithuanian Hungarian Dutch Romanian Finnish Swedish Icelandic Norwegian
Na voljo samo v Bulgarian Spanish Czech Danish German Estonian Greek English French Italian Latvian Lithuanian Hungarian Dutch Romanian Finnish Swedish Icelandic Norwegian
Na voljo samo v Bulgarian Spanish Czech Danish German Estonian Greek English French Italian Latvian Lithuanian Hungarian Dutch Romanian Finnish Swedish Icelandic Norwegian
Na voljo samo v Bulgarian Spanish Czech Danish German Estonian Greek English French Italian Latvian Lithuanian Hungarian Dutch Romanian Finnish Swedish Icelandic Norwegian
Na voljo samo v Bulgarian Spanish Czech Danish German Estonian Greek English French Italian Latvian Lithuanian Hungarian Dutch Romanian Finnish Swedish Icelandic Norwegian

Pot uporabe:

intramuskularna uporaba
Intravenska uporaba

Podatki o zdravilu

Učinkovina / Jakost:

Na voljo samo v English

1.00

international unit(s)

/

1.00

Viala

Farmacevtska oblika:

Suspenzija za injiciranje

Anatomsko-terapevtsko-kemična veterinarska oznaka klasifikacija zdravil, ki se uporabljajo v veterini (ATCvet):

QI07AA02

Pravni status za dobavo/izdajo zdravila:

Zdravilo, ki se izdaja na veterinarski recept

Status dovoljenja za promet z zdravilom:

Valid

Ima dovoljenje za promet v:

Na voljo samo v Spanish Czech German Estonian Greek English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian

Na voljo v:

Cyprus

Opis ovojnine zdravila:

Na voljo samo v Greek

Dodatne informacije

Vrsta dovoljenja:

Na voljo samo v English French Croatian Italian Latvian Finnish Swedish Icelandic Norwegian

Pravna podlaga za izdajo dovoljenja za promet z zdravilom:

Na voljo samo v English Italian Latvian Lithuanian Norwegian

Imetnik dovoljenja za promet z zdravilom:

Boehringer Ingelheim Animal Health France

Datum dovoljenja za promet z zdravilom:

28/04/2006

Proizvodna mesta, odgovorna za sproščanje serij:

MERIAL, Laboratory of Lyon Gerland

Pristojni organ:

Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment

Številka dovoljenja za promet z zdravilom:

CY00018V

Datum spremembe statusa dovoljenja za promet:

26/06/2017

Za poročila o domnevnih neželenih učinkih zdravil za uporabo v veterinaski medicini obiščite stran: www.adrreports.eu/vet

Dokumenti

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.

Drugi jeziki (1)

Greek (PDF)

Objavljeno na dan: 18/06/2024

Prenesi